Table 3.
Comorbidities among DM and non-DM patients
| Comorbidities | Known DM | No known DM | p-value* | ||
|---|---|---|---|---|---|
| n | % | n | % | ||
| Total | 96 | 100 | 1816 | 100 | |
| Myocardial infarct | 6 | 0.6 | 361 | 2.0 | < 0.01 |
| Heart failure | 12 | 12.5 | 30 | 1.7 | < 0.01 |
| Peripheral vascular disease | 10 | 10.4 | 32 | 1.8 | < 0.01 |
| Cerebral vascular disease | 15 | 15.6 | 70 | 3.9 | < 0.01 |
| Dementia | 0 | 0.0 | 5 | 0.3 | 1 |
| Chronic pulmonary disease | 18 | 18.8 | 198 | 10.9 | 0.02 |
| Connective tissue disease | 8 | 8.3 | 57 | 3.1 | < 0.01 |
| Ulcer disease | 10 | 10.4 | 80 | 4.4 | 0.01 |
| Mild liver disease | 10 | 10.4 | 96 | 5.3 | 0.05 |
| Moderate/severe renal disease | 0 | 0.0 | 36 | 2.0 | 0.23 |
| Hemiplegia | 0 | 0.0 | 5 | 0.3 | 1 |
| Tumour | 11 | 11.5 | 78 | 4.3 | < 0.01 |
| Leukaemia | 0 | 0.0 | 5 | 0.3 | 1 |
| Lymphoma | 1 | 1.0 | 9 | 0.5 | 1 |
| Moderate/severe liver disease | 4 | 4.2 | 10 | 0.6 | < 0.01 |
| Metastatic/solid tumour | 0 | 0.0 | 6 | 0.3 | 1 |
| AIDS | 2 | 2.1 | 40 | 2.2 | 1 |
| Charlson Comorbidity Score n, (%) | |||||
| 0–1 | 59 | 6.2 | 1561 | 85.9 | < 0.01** |
| 2–3 | 23 | 23.9 | 174 | 9.6 | < 0.01 |
| 4–5 | 8 | 8.3 | 34 | 1.9 | < 0.01 |
| = > 6 | 5 | 5.2 | 47 | 2.6 | 0.18 |
*p-value from Chi-square test
**p-value < 0.05 was considered significant, when comparing the percentage of DM patients and no-DM patients stratified by Charlson Comorbidity Score